Item type |
学術雑誌論文 / Journal Article(1) |
公開日 |
2018-10-31 |
タイトル |
|
|
タイトル |
Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis |
言語 |
|
|
言語 |
eng |
DOI |
|
|
|
関連識別子 |
https://doi.org/10.1038/ajg.2015.118 |
|
|
関連名称 |
10.1038/ajg.2015.118 |
キーワード |
|
|
主題 |
Autoimmune Liver Disease, Glycoprotein, Biomarker |
資源タイプ |
|
|
資源 |
http://purl.org/coar/resource_type/c_6501 |
|
タイプ |
journal article |
著者 |
Umemura, Takeji
Joshita, Satoru
Sekiguchi, Tomohiro
Usami, Yoko
Shibata, Soichiro
Kimura, Takefumi
Komatsu, Michiharu
Matsumoto, Akihiro
Ota, Masao
Tanaka, Eiji
|
信州大学研究者総覧へのリンク |
|
|
氏名 |
Umemura, Takeji |
|
URL |
http://soar-rd.shinshu-u.ac.jp/profile/ja.ymSpgpkh.html |
出版者 |
|
|
出版者 |
NATURE PUBLISHING GROUP |
引用 |
|
|
内容記述 |
AMERICAN JOURNAL OF GASTROENTEROLOGY.110(6):857-864(2015) |
書誌情報 |
AMERICAN JOURNAL OF GASTROENTEROLOGY
巻 110,
号 6,
p. 857-864,
発行日 2015-04-28
|
抄録 |
|
|
内容記述 |
OBJECTIVES:<br/>Noninvasive markers of liver fibrosis in patients with primary biliary cirrhosis (PBC) are needed for predicting disease progression. As the Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA+-M2BP) was recently established as a liver fibrosis glycobiomarker in chronic hepatitis C, we assessed its efficacy in evaluating liver fibrosis stage and disease progression in PBC.<br/>METHODS:<br/>A total of 137 patients with PBC who underwent liver biopsy and serological tests for WFA+-M2BP were enrolled. All patients were treated with ursodeoxycholic acid. Clinical data were compared with those for other noninvasive markers (aspartate aminotransferase-to-platelet ratio, FIB-4 index, aspartate aminotransferase/alanine aminotransferase ratio, Forn’s index, and Mayo score) for estimating liver fibrosis using receiver operating characteristic analysis. The association between WFA+-M2BP and clinical outcome (liver decompensation, liver transplantation, or death) was evaluated using the Cox proportional hazards model with stepwise method.<br/>RESULTS:<br/>WFA+-M2BP was independently associated with liver fibrosis stage as determined by liver biopsy. The cutoff values of WFA+-M2BP for fibrosis stages ≥F1, ≥F2, ≥F3, and F4 were 0.7, 1.0, 1.4, and 2.0, respectively. The area under the receiver operating characteristic curve values for significant fibrosis, severe fibrosis, and cirrhosis were 0.979, 0.933, and 0.965, respectively. WFA+-M2BP was significantly superior to the other indices for the determination of significant and severe fibrosis stages. Furthermore, the WFA+-M2BP level at enrollment was strongly and independently associated with clinical outcome (hazard ratio 18.59, P=0.021).<br/>CONCLUSIONS:<br/>Baseline measurements of WFA+-M2BP represent a simple and reliable noninvasive surrogate marker of liver fibrosis and prognosis in patients with PBC. |
資源タイプ(コンテンツの種類) |
|
|
内容記述 |
Article |
ISSN |
|
|
収録物識別子タイプ |
PISSN |
|
収録物識別子 |
0002-9270 |
書誌レコードID |
|
|
収録物識別子タイプ |
NCID |
|
収録物識別子 |
AA00520662 |
PubMed |
|
|
|
関連識別子 |
https://www.ncbi.nlm.nih.gov/pubmed/25916223 |
|
|
関連名称 |
25916223 |
出版タイプ |
|
|
出版タイプ |
AM |
|
出版タイプResource |
http://purl.org/coar/version/c_ab4af688f83e57aa |
WoS |
|
|
URL |
http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=ShinshuUniv&SrcApp=ShinshuUniv&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000357081800013 |